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To date, no studies have investigated the role of Mnk1 in pressure overload-induced cardiac remodeling. We hypothesized that Mnk1 may mediate beneficial effects through its ability to keep the stability of sprouty2 and to promote the translation of Bcl-2. In this study, we investigated one knockout mouse line globally lacking Mnk1 (Mnk1-KO) 11 and neonatal rat ventricular myocytes (NRVMs) lacking or overexpressing Mnk1 and further aimed to discriminate its role in cardiac remodeling.
Methods
All animal procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996) 
Statistical Analysis
Data are presented as mean±SEM. Statistical analysis was performed using SPSS 13.0 (SPSS, Inc) software. Data were analyzed by 1-way ANOVA followed by Tukey post hoc test. P values <0.05 were considered as statistically significant.
Results
Activation of Mnk1 in Myocardium in Response to Pressure Overload
We first detected the protein expression of total Mnk1 and phosphorylated Mnk1 (phospho-Mnk1) in pressure overloadinduced murine hearts. It turned out that the cardiac expression of Mnk1 did not change, but phospho-Mnk1, which indicates the activation state of Mnk1, was upregulated at 2 weeks and 4 weeks after transverse aortic constriction (TAC); however, a subsequent decompensatory decrease in Mnk1 activation occurred from 6 weeks after TAC ( Figure 1A ).
Lacking Mnk1 Leads to Deteriorated Cardiac Hypertrophy and Dysfunction
To test whether Mnk1 contributes to cardiac hypertrophy, we challenged Mnk1-KO mice and their wild-type (WT) control mice ( Figure 1B ) with pathological pressure overload induced by TAC. The degree of TAC was similar in Mnk1-KO and WT mice as indicated by end-systolic pressure in the 2 groups (Table S1 ). Four weeks after TAC, Mnk1-KO mice showed a strikingly larger heart and increased cardiomyocyte cross-sectional area than WT animals ( Figure 1C and 1D). Mnk1-KO mice also represented increased ratios of heart weight to body weight or tibia length and ratios of lung weight to body weight ( Figure 1E ). In addition, as shown by increased interventricular septum thickness at diastole, left ventricular end-diastolic diameter, left ventricular end-systolic diameter, and left ventricular end-diastolic posterior wall thickness( Figure S1A in the online-only Data Supplement), the accelerated effect of Mnk1 deficiency on TAC-induced hypertrophic response was confirmed. Moreover, 4 weeks after TAC, Mnk1-KO mice showed a decline in cardiac contractility as indicated by reduced ejection fraction, fractional shortening, maximal rate of pressure development, cardiac output, and stroke volume ( Figure S1A ; Table S1 ). Mnk1-KO mice also showed deteriorated cardiac diastolic function as indicated by reduced minimum rate of pressure development and increased time constant of isovolumic pressure decay (Table S1 ). Consistently, the expression of cardiac fetal genes including atrial natriuretic factor, brain natriuretic peptide, β-myosin heavy chain were significantly augmented in Mnk1-KO mice after TAC, whereas the expression of α-myosin heavy chain was significantly decreased ( Figure S1B ). Thus, Mnk1 deficiency remarkably renders the heart more susceptible to pressure overload-induced cardiac hypertrophy and dysfunction.
Mnk1 Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy In Vitro
Western blot analysis showed that angiotensin II (Ang II; 1 μmol/L) treatment for 24 or 48 hours significantly increased phospho-Mnk1 expression while had no effects on total Mnk1 in NRVMs (Figure 2A ), suggesting the activation of Mnk1 in response to Ang II stimulation. Next, we performed both gainof-function and loss-of-function studies using NRVMs. Mnk1 knockdown, which resulted in ≈70% decrease of Mnk1 protein ( Figure 2B 
Mnk1 Inhibits ERK1/2 Signaling Associated With Sprouty2
We further gained insight into the molecular events mediating the antihypertrophic effect of Mnk1. It was reported that ERK1/2 phosphorylation can be suppressed by sprouty2, 12, 13 which is a substrate of Mnk1. Thus, we detected the protein expression of phospho-ERK1/2 and sprouty2 in sham-and TAC-operated Mnk1-KO/WT mice. We found the pressure overload-induced ERK1/2 activation to be strongly upregulated in Mnk1-KO mice after 4 weeks of TAC ( Figure 3A) . Meanwhile, we found that sprouty2 expression was markedly downregulated in heart of Mnk1-KO mice subjected to TAC ( Figure 3A ). In line with this in vivo data, Mnk1 knockdown in NRVMs resulted in hyperphosphorylation of ERK1/2 and decreased sprouty2 expression after Ang II stimulation ( Figure 3B ). It implies that ERK1/2 and sprouty2 possibly involves in the regulating process of cardiac remodeling by Mnk1. The interaction between Mnk1 and ERK1/2 signaling was further confirmed by immunoprecipitation experiments. Because GRB2 is the link protein between sprouty2 and ERK1/2, we investigated the interaction between sprouty2 and GRB2 in NRVMs. A significant decrease of interaction between sprouty2 and GRB2 in NRVMs with Mnk1 knockdown was observed not only in the basal environment but also under the treatment of Ang II ( Figure 3C ). Consistently, Mnk1 overexpression significantly suppressed ERK1/2 activation in Ang II-stimulated NRVMs ( Figure S3A ). These data indicate that Mnk1 may specifically inhibit ERK1/2 signaling pathway through the interaction of its substrate sprouty2 with GRB2. To verify the role of sprouty2, we overexpressed sprouty2 in NRVMs with Mnk1 knockdown ( Figure S3B and S3C). After 48 hours of Ang II stimulation, sprouty2 overexpression remarkably suppressed atrial natriuretic factor mRNA levels and ERK1/2 phosphorylation levels ( Figure S3D and S3E).
To confirm the role of sprouty2 in the hypertrophic response in Mnk1-KO mice, AdSpry2 or AdGFP was injected in the cardiac wall of mice right after TAC surgery ( Figure S4A ). Left ventricular hypertrophy was evaluated after 4 weeks by echocardiography and hemodynamics. AdSpry2 treatment efficiently reduced crosssectional area, heart weight to body weight ratio, lung weight to body weight ratio, heart weight to tibia length ratio, interventricular septum thickness at diastole, left ventricular end-diastolic diameter, left ventricular end-systolic diameter, left ventricular end-diastolic posterior wall thickness, and the cardiac fetal genes expression ( Figure S4B through S4E). Cardiac function changed accordingly ( Figure S4D ; Table S2 ). MnK1-KO mice with overexpression of sprouty2 exhibit signs of a blunted cardiac hypertrophic response along with reduced ERK activation ( Figure S4F ). These findings suggest that the antihypertrophic effect of Mnk1 is associated with the suppression of ERK1/2 activation via regulation of sprouty2. 
Lacking Mnk1 Leads to Deteriorated Cardiac Fibrosis
The changes in Mnk1-KO hearts after pressure overload also included an increased interstitial fibrosis and perivascular fibrosis as compared with the WT mice ( Figure S5A ). The mRNA expression levels of fibrotic markers, including connective tissue growth factor, collagen Iα, collagen IIIα, and fibronectin, were significantly augmented in Mnk1-KO mice after TAC ( Figure  S5B ). These results indicate that Mnk1 deficiency leads to deteriorated cardiac fibrosis. Consistently, the transforming growth factor β (TGFβ) and Smad1/5 signaling pathway were significantly enriched ( Figure S5C ). We further did loss-of-function and gain-of-function studies of Mnk1's effect on Ang II-induced profibrotic marker expressions in cardiac fibroblasts and found that neither Mnk1 knockdown nor overexpression changed the profibrotic marker expressions (connective tissue growth factor, collagen Iα, collagen IIIα, and fibronectin) in Ang II-treated cardiac fibroblasts (data not shown). However, it was further found that adenovirus transfection-based Mnk1 overexpression led to decreased TGFβ mRNA levels in Ang II-treated NRVMs as compared with the AdGFP group ( Figure S5D ). However, Mnk1 overexpression did not make a difference to TGFβ mRNA expression in Ang II-treated cardiac fibroblasts as compared with AdGFP group (Figure S5E ).
Apoptosis Is Exaggerated in Mnk1-KO Mice After TAC and Mnk1-Silenced NRVMs Stimulated by Ang II
TAC increased the number of TUNEL-positive cells in both WT and Mnk1-KO mice, but the magnitudes of increase were slightly larger in Mnk1-KO mice ( Figure S6A ). To examine changes in the molecules involved in apoptosis signaling, we quantified cleaved-caspase3, Bax, and Bcl-2 proteins in WT and Mnk1-KO mice and found that the expression levels of cleavedcaspase3 and Bax were significantly increased in Mnk1-KO mice as compared with WT mice. Moreover, the expression of Bcl-2 was significantly decreased in Mnk1-KO mice as compared with WT mice ( Figure S6B ). Because the eIF4E phosphorylation may link Mnk1 with Bcl-2, we detected total and phosphorylated eIF4E in murine hearts in the indicated groups and found that Mnk1-KO mice displayed decreased expression of phosphorylated eIF4E as compared with the WT mice after TAC ( Figure S6C ). In line with the in vivo result, Ang II increased the number of TUNEL-positive cells in NRVMs transfected with nontargeting or Mnk1 siRNA, but the magnitudes of increase were much larger in Mnk1 siRNA-transfected NRVMs ( Figure S6D ).We also found that Mnk1 knockdown led to decreased Bcl-2 expression in Ang II-treated NRVMs as compared with the control cells ( Figure S6E ). It was further confirmed that Mnk1 overexpression increased Bcl-2 expression in Ang II-treated NRVMs as compared with AdGFP group ( Figure S6F ).
Discussion
The absence of endogenous Mnk1 results in severe cardiac hypertrophy, fibrosis, dysfunction, and cardiomyocyte apoptosis. Consistent with the in vivo data, siRNA-mediated lossof-function approaches indicate that decreased expression of endogenous Mnk1 promoted cardiomyocyte hypertrophy in cardiomyocytes after Ang II stimulation, and adenovirus-mediated Mnk1 overexpression suppresses Ang II-induced cardiomyocyte hypertrophy and cardiomyocyte TGFβ mRNA expression. Impressively, the in vivo and the in vitro studies suggest that the antihypertrophic effect of Mnk1 is likely associated with suppression of ERK1/2 activation via regulation of sprouty2. Our results suggest that Mnk1 may be an indispensable endogenous-negative regulator of cardiac remodeling.
Recent studies have pointed out the significant role of sprouty2, a substrate of Mnk1, during multiple diseases or physiological process such as human mesenchymal stem cell differentiation, 17 papillary thyroid cancer, 18 and prostate cancer progression 19 by regulating ERK signaling pathway. ERK1/2 is one of the most important signaling that could provide new treatment strategies for cardiac hypertrophy and remodeling. [20] [21] [22] In our study, phospho-ERK1/2 expression increased while sprouty2 expression decreased in pressure overload-induced Mnk1-KO mice and Ang II-treated Mnk1-silencing NRVMs as compared with the controls. Consistently, Mnk1 overexpression in NRVMs significantly suppressed the activation of ERK1/2 after Ang II stimulation. Because the phosphorylation of sprouty2 by Mnk1 may protect sprouty2 from degradation, 4 and it has been reported that sprouty2 could inhibit the Ras/ERK pathway through binding to GRB2 1, 2 , in this study, it is reasonable that Mnk1 deficiency induces decreased sprouty2 expression and increased ERK1/2 activation. Coimmunoprecipitation assay showed that Mnk1 knockdown decreased the binding of sprouty2 to GRB2 not only in the basal environment but also under the treatment of Ang II. We speculated that a decline in sprouty2 stability because of Mnk1 knockdown leads to decreased binding of sprouty2 to GRB2, resulting in hyperactivation of ERK1/2 signaling pathway. However, in basal environment, phospho-ERK1/2 expression in Mnk1-KO mice and WT ones did not show any differences, indicating that the misbalance of ERK1/2 in heart only appeared under stress. To verify the role of sprouty2, we simultaneously overexpressed sprouty2 in NRVMs with Mnk1 knockdown. After 48 hours of Ang II treatment, sprouty2 overexpression remarkably suppressed atrial natriuretic factor mRNA levels and ERK1/2 phosphorylation levels. Sprouty2 overexpression in Mnk1-KO mice consistently caused a blunted hypertrophic response. Collectively, these findings suggest that the antihypertrophic effect of Mnk1 is associated with suppression of ERK1/2 activation, which is likely mediated by sprouty2.
Chronic pressure overload is associated with excessive forms of collagen deposition or fibrosis, which affects myocardial compliance characteristics with a resulting increase in myocardial stiffness. 23, 24 Results of this study impressively show that Mnk1 deficiency dramatically increase interstitial fibrosis and perivascular fibrosis and compromise cardiac diastolic dysfunction. This is plausible when considering that ERK1/2 serves as an important pathway in the fibrotic response by promoting activation of fibrotic pathways like smad1/5 pathways 25, 26 and production of profibrotic factors such as TGFβ. 27 Here, we observed increased TGFβ expression and activation of smad1/5 pathways in Mnk1-KO murine hearts subjected to TAC. We also found that Mnk1 overexpression led to decreased TGFβ mRNA levels in Ang II-treated NRVMs but did not affect TGFβ mRNA levels in Ang II-treated cardiac fibroblasts, as compared with the AdGFP group. Therefore, the accelerated fibrosis in the hearts of Mnk1-KO mice after TAC is likely because of the increased TGFβ expression derived from cardiomyocytes.
Studies also have provided evidence for an important role of Mnk1 in several pathophysiological processes of several diseases via phosphorylation of eIF4E, such as pancreatic acinar cell maturation, 28 multiple myeloma expansion, 29 and nasopharyngeal carcinoma. 30 eIF4E is an oncogenic rate-limiting factor of cap-dependent translation of several mRNA including Bcl-2. 31 Mnk1-eIF4E axis and Bcl-2 expression are intimately associated with apoptosis in several types of cells. [32] [33] [34] Our studies suggest that Mnk1-eIF4E axis and Bcl-2 may affect cardiomyocytes apoptosis. However, effect of Mnk1-eIF4E axis on mRNA translation and protein synthesis is complex. In vascular smooth muscle cells, the activation of Mnk1/eIF4E pathway contributes to Ang II-induced protein synthesis and hypertrophy. 35 One recent research demonstrated that Mnk inhibitor CGP57380 affected translation of only those mRNAs that contain both a cap and a hairpin in the 5′-untranslated regions. 36 Mnk1 may affect translation of specific mRNAs in different cells. In our research, we cannot exclude the possibility that Mnk1 affect the expression of Bcl-2 via another molecule or signaling pathway.
Perspectives
Our study provides evidence that Mnk1 may be a critical negative regulator of cardiac remodeling via inhibition of sprouty2-dependent ERK1/2 signaling and promoting Bcl-2 expression. These findings expand our understanding of the roles of Mnk1 in the heart. We propose that targeting Mnk1 may develop novel promising strategies for reversing cardiac remodeling.
• Mnk1 knockdown exaggerated cardiomyocyte hypertrophy and apoptosis in angiotensin II-treated neonatal rat ventricular myocytes. Sprouty2 overexpression rescued the neonatal rat ventricular myocytes with Mnk1 knockdown from angiotensin II-induced hypertrophy.
• Mnk1 overexpression in neonatal rat ventricular myocytes protected the cells from angiotensin II-induced cardiomyocyte hypertrophy. Sprouty2 overexpression in Mnk1-knockout mice caused a blunted hypertrophic response.
What Is Relevant?
• This study indicates that therapeutic approaches to regulate Mnk1/ sprouty2 signaling pathways may be useful for prevention and treatment of cardiac remodeling and heart failure. 
Echocardiography and hemodynamics
Cardiac function was determined by transthoracic echocardiography and hemodynamic analysis. Echocardiography was performed in mice anesthetized with 1.5% isoflurane, using a Mylab 30CV (ESAOTE S. P. A) equipped with a 10-MHz linear-array ultrasound transducer. Body temperature was maintained at 37°C using a heating pad. The left ventricle (LV) dimensions were assessed in the parasternal short-axis view. M-mode tracings were used to measure interventricular septal thickness at diastole (IVSd), left ventricular end-diastolic diameter (LVEDd), left ventricular end-systolic diameter (LVESd) and left ventricular end-diastolic posterior wall thickness (LVPWd), ejection fraction (EF), and fractional shortening (FS). End-diastole was defined as the phase in which the largest area of the LV was obtained.
For hemodynamic measurements, a microtip catheter transducer (SPR-839, Millar Instruments, Houston, TX, USA) was inserted into the right carotid artery and advanced into the left ventricle of mice anesthetized with 1.5% isoflurane. The signals were continuously recorded using a Millar Pressure-Volume System (MPVS-400, Millar Instruments, Houston, TX, USA), and the data were processed by PVAN data analysis software. All measurements were made by the observer who was blinded with respect to the identity of the tracings.
After the invasive hemodynamic measurements, mice were euthanized by cervical dislocation. Hearts, lungs and tibiae of the sacrificed mice were dissected and weighed or measured to compare the heart weight/body weight (HW/BW, mg/g), lung weight/body weight (LW/BW, mg/g), and heart weight/tibia length (HW/TL, mg/mm) ratios in KO and WT mice.
Histology
Excised hearts were arrested in diastole with 10% KCl, weighed, fixed by perfusion with 10% formalin, and embedded in paraffin. The hearts were cut transversely close to the apex to visualize the left and right ventricles. Several sections of each heart (4-5 μm thick) were prepared, stained with hematoxylin-eosin (HE) and picrosirius red (PSR) to determine the cardiomyocyte cross-sectional area (CSA) and collagen deposition, and were measured using a quantitative digital image analysis system (Image Pro-Plus, version 6.0).
